Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Leukemia, B-Cell × Ciprofloxacin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Infections 3 Prostatic Neoplasms 2 Breast Neoplasms 2 Urinary Tract Infections 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Staphylococcal Infections 1 Squamous Cell Carcinoma of Head and Neck 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Pancreatic Cyst 1 Pain 1 Neutropenia 1 Neoplasms 1 Multiple Myeloma 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Leukemia, B-Cell 1 Intraabdominal Infections 1 Influenza, Human 1 Inflammation 1

Interventions

ofatumumab 10 Rituximab 6 ibrutinib 5 Cyclophosphamide 5 fludarabine phosphate 4 Bendamustine Hydrochloride 4 fludarabine 3 Lenalidomide 3 Alemtuzumab 3 spebrutinib 2 navitoclax 2 acalabrutinib 2 KW-2478 2 venetoclax 1 tirabrutinib 1 obinutuzumab 1 idelalisib 1 dinaciclib 1 Tablets 1 Stem Cell Transplantation 1 Rabeprazole 1 Pentostatin 1 Metronidazole 1 Methylprednisolone 1 Magnetic Resonance Imaging 1 Leukapheresis 1 Lansoprazole 1 Itraconazole 1 Immunotherapy, Adoptive 1 Hsp90 inhibitor KU757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01279252 2019-01-25

CLEAR

King's College Hospital NHS Trust

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡